BioHealth News Archive
Reforming U.S. Regulation to Achieve Better Science – Ideas Lab
A bipartisan initiative known as “21st Century Cures,” spearheaded by the House Energy and Commerce Committee, is aiming to keep the U.S. at the…
Read More
Decentralising drug research: Pharmed out – The Economist
IAN READ, the chief executive of Pfizer, is not a man easily rebuffed. His attempt to woo AstraZeneca, a British drugs firm, included politesse—appearances…
Read More
Imperial Innovations and SR One lead £850,000 seed financing for Puridify – Imperial Innovations
Imperial Innovations Group plc (AIM:IVO, ‘Innovations’), the leading technology commercialisation and investment company and S.R.One Ltd, GlaxoSmithKline’s venture captial fund, announce today that they…
Read More
MedImmune advancing cancer research – Cambridge News
Immunotherapy, a new, promising therapeutic approach that leverages the power of the immune system to fight cancer, is the cornerstone of MedImmune’s oncology portfolio.…
Read More
Bioscience firms integral part of Frederick County’s economy – The Frederick News-Post
The changing face of Frederick County’s economy is reflected in the rapidly growing field of bioscience and biotechnology companies locating or expanding here. Agriculture…
Read More
Why Pfizer Abandoned the AstraZeneca Takeover (Video) – The Business Journals
Bloomberg’s Drew Armstrong reports on the failed Pfizer and AstraZeneca merger on Bloomberg Television’s “Bloomberg Surveillance.” {iframe}http://www.bizjournals.com/bizjournals/video/ZpZ2MybjpT1VXJtZ9XGr_FAEvRAKPh9B?autoplay=1&ana=e_wash_rdup&s=newsletter&ed=2014-05-28&u=wjGEy67ABoSnsLErlc5ry0j5hx3&t=1401287382{/iframe}
Read More
Epidarex unveils £50m venture capital fund for UK life sciences – Telegraph
Investors keen to capitalise on British science have poured nearly £50m into a new venture capital fund. Epidarex, a specialist life science venture capital…
Read More
Meet NHLBI at the 2014 National SBIR/STTR Conference Sign Up for 1-on-1 Meetings Today
Register for the Spring National SBIR/STTR Conference and take your pick of 1-on-1 meetings with Agency principals on a first-come, first-serve basis. More than…
Read More
BIO Statement on Removal of Patent Legislation from Judiciary Committee Agenda | BIO
The Biotechnology Industry Organization today issued the following statement in response to Senator Patrick Leahy’s announcement that he will remove current patent legislation from…
Read More
Health Care Becomes Entrepreneurial (Finally) – Sachin H. Jain, and Thomas Tsang – Harvard Business Review
All of us know that you have to be a little crazy to be an entrepreneur. Launching, let alone sustaining, a new enterprise can…
Read More
Do Genes Affect Our Attitudes Toward Interdependence? – Andrew O’Connell – Harvard Business Review
Numerous studies have shown that Americans of European origin have a more independent, and Asians have a more interdependent, social orientation, as measured by…
Read More
Perspective: Why Should We Crowdfund Research? – Crowdfund Insider
Its no secret: the University of Colorado receives hundreds of millions of dollars in federal funds that sponsor our research. My lab alone racks…
Read More
Protenus: DreamIt Health grad raising $750K for health records’ cybersecurity » Technical.ly Baltimore
Take a guess as to which industry suffered the most cybersecurity breaches in 2013. According to one health IT startup, that’s healthcare. Protenus pointed that out…
Read More
QIAGEN Receives FDA Approval of therascreen® KRAS RGQ PCR Kit Paired with Second Colorectal Cancer Drug – MarketWatch
QIAGEN N.V. (frankfurt prime standard:QIA) today announced that its therascreen® KRAS RGQ PCR Kit (therascreen KRAS test) has received U.S. Food and Drug Administration…
Read More
DoD 2014.2 SBIR Solicitation Now Open
The DoD SBIR 2014.2 solicitation is now available for the submission of proposals.Participating Department of Defense (DoD) agencies: Army Navy DARPA DLA DMEA Missile…
Read More